Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio
In This Article:
Alnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Alnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.